Qube Research & Technologies (QRT)’s Cue Health Inc. Common Stock HLTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-5,186
Closed -$978 4931
2024
Q1
$978 Buy
5,186
+1,341
+35% +$305 ﹤0.01% 4039
2023
Q4
$625 Sell
3,845
-13,419
-78% -$4.45K ﹤0.01% 3900
2023
Q3
$7.64K Sell
17,264
-136,523
-89% -$62.3K ﹤0.01% 3370
2023
Q2
$56.7K Buy
+153,787
New +$131K ﹤0.01% 2056
2022
Q3
Sell
-222,824
Closed -$713K 3170
2022
Q2
$713K Buy
+222,824
New +$1.21M 0.01% 1260
2021
Q4
Sell
-15,400
Closed -$182K 3073
2021
Q3
$182K Buy
+15,400
New +$243K ﹤0.01% 1681

Other funds holding HLTH

Qube Research & Technologies (QRT)'s HLTH Position: Q2 2024 in Review

Qube Research & Technologies (QRT) sold out of Cue Health Inc. Common Stock (HLTH) in Q2 2024, closing a stake of 5,186 shares — an estimated $978 sold.

Qube Research & Technologies (QRT) first reported a position in HLTH in Q3 2021 and held it in 6 quarters. The position peaked at $713K in Q2 2022. 9 funds tracked by Wall St. Rank hold HLTH as of Q2 2024.

  • Qube Research & Technologies (QRT) reported no remaining Cue Health Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 5,186 Cue Health Inc. Common Stock shares in Q2 2024, an estimated $978.
  • Qube Research & Technologies (QRT) first reported a position in Cue Health Inc. Common Stock in Q3 2021 and held it in 6 quarters.
  • Qube Research & Technologies (QRT)'s Cue Health Inc. Common Stock position peaked at $713K in Q2 2022.
  • 9 funds tracked by Wall St. Rank held Cue Health Inc. Common Stock as of Q2 2024.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2024, filed 14 Aug 2024.